BioCentury | Oct 28, 2019
Enleofen co-founders identify IL-11 as pulmonary fibrosis target
...DISEASE CATEGORY: Pulmonary INDICATION: Pulmonary fibrosis A National Heart Centre Singapore team led by Enleofen Bio Pte. Ltd. co-founders...
...al. Sci. Transl. Med. ; published online Sept. 25, 2019 doi:10.1126/scitranslmed.aaw1237 CONTACT: Stuart A. Cook, National Heart Centre Singapore...
...al. Sci. Transl. Med. ; published online Sept. 25, 2019 doi:10.1126/scitranslmed.aaw1237 CONTACT: Stuart A. Cook, National Heart Centre Singapore...
